Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Proof-of-concept Study of BI 655130 add-on Treatment in Patients With Mild-to-moderately Active Ulcerative Colitis During TNF Inhibitor Therapy

NCT03123120 is registered in ClinicalTrials.gov with Boehringer Ingelheim as lead sponsor.

NCT NCT03123120
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03123120 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Proof-of-concept Study of BI 655130 add-on Treatment in Patients With Mild-to-moderately Active Ulcerative Colitis During TNF Inhibitor Therapy
Lead sponsor
Boehringer Ingelheim
Phase
Phase 2
Overall status
Completed
Start date
June 7, 2017
Completion date
September 16, 2020
Enrollment
22 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

colitis, ulcerative